loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 50207 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Azurity Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ERYTHROMYCIN ETHYLSUCCINATE (3)

    filter

    01 AZURITY (3)

    filter

    01 GRANULE;ORAL (3)

    filter

    01 EQ 200MG BASE/5ML (2)

    02 EQ 400MG BASE/5ML (1)

    filter

    01 USA (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Erythromycin Ethylsuccinate

      PDF Supplier PDF
      URL Supplier Web Content
      GRANULE;ORAL
      EQ 400MG BASE/5ML
      ERYPED
      USA
      50207
      1982-01-01
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Erythromycin Ethylsuccinate

        PDF Supplier PDF
        URL Supplier Web Content
        GRANULE;ORAL
        EQ 200MG BASE/5ML
        ERYPED
        USA
        50207
        1987-03-30
        RX
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Erythromycin Ethylsuccinate

          PDF Supplier PDF
          URL Supplier Web Content
          GRANULE;ORAL
          EQ 200MG BASE/5ML
          E.E.S.
          USA
          50207
          1982-01-01
          RX
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for CTD TGA MCC DOSSIER APPLICATION 50207

          Looking for CTD TGA MCC DOSSIER APPLICATION 50207 3

          19

          Azurity Pharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 50207 and regulatory information .

          proudly manufactured in the

          approval since 1982-01-01

          Azurity Pharma's ERYPED GRANULE;ORAL, medication with EQ 400MG BASE/5ML of ERYTHROMYCIN ETHYLSUCCINATE.

          18

          Azurity Pharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 50207 and regulatory information .

          proudly manufactured in the

          approval since 1987-03-30

          Azurity Pharma's ERYPED GRANULE;ORAL, medication with EQ 200MG BASE/5ML of ERYTHROMYCIN ETHYLSUCCINATE.

          17

          Azurity Pharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 50207 and regulatory information .

          proudly manufactured in the

          approval since 1982-01-01

          Azurity Pharma's E.E.S. GRANULE;ORAL, medication with EQ 200MG BASE/5ML of ERYTHROMYCIN ETHYLSUCCINATE.

          Post Enquiry
          POST ENQUIRY